Latest Product Innovation News

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Bell Financial Group surged to a $21.7 million half-year profit, more than doubling its net profit on stronger markets and the launch of its Bell Potter Private Wealth platform. The company also lifted its interim dividend by 67%, reflecting confidence in its diversified financial services model.

SEEK Limited delivered solid operational growth with record dividends in FY2026, yet posted a hefty net loss driven by a $284m impairment on its Chinese associate Zhaopin and a $201m loss from its Growth Fund.

AGL Energy reported a 575% surge in statutory profit to $756 million for FY26, driven by strategic divestments and improved asset flexibility, while declaring a fully franked 50 cents dividend and progressing its energy transition with 12 GW of renewable capacity targeted by 2035.

Elixinol Wellness (ASX: EXL) has posted a record quarterly revenue of A$4.3 million alongside a 45% gross margin, marking a clear shift from its US CBD origins to a diversified Australian wellness platform. Cost reductions and disciplined cash flow management underpin the company’s readiness to scale.

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

Aura Consolidated Group delivers strong pro forma Q2 2026 results with 27% revenue growth and a 51% improvement in adjusted EBITDA following its acquisition of Qoria.

REA Group Ltd (ASX:REA) posted a robust FY26 with revenue up 7% to A$1.793 billion and core net profit rising 15% to A$682 million, supported by record audience engagement and strategic AI investments.

Neuren Pharmaceuticals saw a record Q2 with DAYBUE net sales hitting US$125 million, driven by strong uptake of the new STIX formulation. The company upgraded its 2026 royalty guidance following Acadia Pharmaceuticals’ sales boost and awaits key regulatory milestones in Europe and Japan.

Light & Wonder's Q2 2026 sees net income jump 26% to $120 million, driven by strong Gaming and iGaming growth. The company sticks to its 2026 outlook, targeting mid- to high-single-digit EBITDA growth and aims to reduce leverage below 3.0x by mid-2027.

Pinnacle Investment Management delivered a 31.5% jump in net profit after tax to $176.7 million for FY26, boosted by full ownership of Pacific Asset Management and strong inflows across retail, institutional, and international channels.

Unith Ltd has issued over 222 million securities, raising $1 million via share placement and converting $500,000 of debt to equity, while attaching options await shareholder approval.